Last reviewed · How we verify
NCT01488539
Implementation of an Evidence Based Post-Traumatic Stress Disorder (PTSD) Treatment in Public Sector Settings
NA trial testing STAIR/NT treatment in Post-Traumatic Stress Disorder in 210 participants. Completed in 1 April 2017.
1 April 2016
Quick facts
| Lead sponsor | Palo Alto Veterans Institute for Research |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 210 |
| Start date | 1 January 2012 |
| Primary completion | 1 April 2016 |
| Estimated completion | 1 April 2017 |
| Sites | 5 locations across United States |
Drugs / interventions tested
- STAIR/NT treatment
- Treatment as Usual (TAU) — full drug profile →
Conditions studied
- Post-Traumatic Stress Disorder — all drugs for Post-Traumatic Stress Disorder →
Sponsor
Palo Alto Veterans Institute for Research
Who can join
Adults 18 to 65, female only, with Post-Traumatic Stress Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Researchers hope to learn whether a flexibly applied cognitive behavioral treatment for Post-Traumatic Stress Disorder (PTSD) is more effective than the psychotherapy usually provided in the clinic (called Treatment as Usual or TAU). Primary Hypothesis: STAIR/NT will be superior to TAU in improving PTSD symptoms at 28, 36 and 48 weeks post-randomization
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Depression as a moderator of STAIR Narrative Therapy for women with post-traumatic stress disorder related to childhood abuse.
Cloitre M, Garvert DW, Weiss BJ. · · 2017 · cited 9× · PMID 29038682 · DOI 10.1080/20008198.2017.1377028 -
A multi-site single-blind clinical study to compare the effects of STAIR Narrative Therapy to treatment as usual among women with PTSD in public sector mental health settings: study protocol for a randomized controlled trial.
Cloitre M, Henn-Haase C, Herman JL, Jackson C, et al · · 2014 · cited 8× · PMID 24886235 · DOI 10.1186/1745-6215-15-197
Verify or expand the search:
- PubMed search for NCT01488539
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Post-Traumatic Stress Disorder
Currently open trials in the same condition.
- NCT06332209 — Randomized Trial of Tele Vs. Clinic TF-CBT in Puerto Rico · NA · recruiting
- NCT06117306 — MDMA-assisted Massed Prolonged Exposure for PTSD · Phase 3 · recruiting
- NCT06002633 — Approach-Avoidance and Alcohol Challenge Study in PTSD · NA · recruiting
- NCT05254405 — An Open Label Pilot Study of IV Brexanolone for the Treatment of Post-Traumatic Stress Disorder · Phase 4 · recruiting
- NCT04152993 — Responsive Neurostimulation for Post-Traumatic Stress Disorder · EARLY_PHASE1 · recruiting
Other Palo Alto Veterans Institute for Research trials
Trials by the same sponsor.
- NCT07219251 — Engagement of Veterans With Lung Cancer · NA · recruiting
- NCT06704061 — Online Yoga vs Acceptance and Commitment Therapy for Treating Chronic Musculoskeletal Pain · NA · recruiting
- NCT07069517 — Accelerated Treatment for Co-occurring Insomnia, Nightmares, and PTSD · NA · recruiting
- NCT07303725 — Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology · recruiting
- NCT07303712 — Liquid Biopsy for Hepatocellular Carcinoma Molecular Characterization After Y90 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT01488539 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Palo Alto Veterans Institute for Research
- Last refreshed: 18 August 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01488539.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing